News - BioPharm International

ADVERTISEMENT

News

Pfizer and GlaxoSmithKline Form Pact in Combination Cancer Trial

November 22, 2013

Phase I/II study to evaluate treatment of patients with melanoma using Pfizer’s palbociclib and GSK’s trametinib.

Pharmaceutical Industry Growth Rebounds in Five-Year Outlook

November 22, 2013

Annual growth in spending for medicines is expected to rise from 2-3% in 2013 to 5-7% in 2017, the highest pace of growth since 2009.

Patheon to Merge with DSM Pharmaceutical Products

November 19, 2013

New CDMO to be formed from the combination of DSM Pharmaceutical Products and Patheon in a $2.6-billion transaction.

Eli Lilly Plans Insulin Manufacturing Investments

November 14, 2013

Ei Lilly announces investments in insulin manufacturing capacity for its sites in Indianapolis, Puerto Rico, France, and China.

Shire To Acquire Rare-Disease Company ViroPharma

November 11, 2013

Shire's agreement to acquire ViroPharma will strengthen its rare-disease portfolio.

AstraZeneca to Invest in New Manufacturing Facility for Injectable Drug

November 11, 2013

AstraZeneca will build a new facility in the United Kingdom to produce Zoladex, an injectable prostrate cancer treatment.

Grifols Purchases Novartis Transfusion Diagnostics Unit

November 11, 2013

Grifols expands and diversifies portfolio with acquisition of diagnostic business.

BIO Throws its Support for Start-up Jobs and Innovation Act

November 7, 2013

Biotechnology Industry Organization President James Greenwood writes senators in support of Start-up Jobs and Innovation Act.

Novartis Announced as Facility of the Year Awards Overall Winner

November 6, 2013

ISPE names Novartis' US Flu Cell Culture facility as award winner.

ADVERTISEMENT

ADVERTISEMENT

Click here